Clinical trial
Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
NCT01262586
Study timeline
Study start (unknown)2010-11-01Date precision: month
Registry last updated2016-11-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type II Diabetes Mellitusunresolved
Interventions
VildagliptinDRUG
GlimepirideDRUG · verified · RxNorm: glimepiride
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01262586 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.